Meet our leadership

AMSilk’s management team consists of experienced executives with both deep and broad experience. Including the brightest minds in science who helped invent biotech silk proteins as well as experienced industry and finance executives. We are driving the change to better and more sustainable products and it is our goal to make the world’s best and most sustainable bio materials accessible to everyone.

Ulrich Scherbel

After studying textile chemistry, Ulrich Scherbel has acquired more than 25 years of global expertise in performance textiles. He has held various positions in multinational companies in the areas of business development, sales, operations and general management. Prior to joining AMSilk, Ulrich served as General Manager Global Apparel Division at Freudenberg Performance Materials, one of the leading global companies in the field of innovative textiles.

Ulrich joined AMSilk 2020 as COO for the expansion of industrial production and sales. In 2021, Ulrich was appointed CEO of AMSilk. While he continues to drive business growth, as CEO Ulrich started to lead the strategic expansion of AMSilk’s Silk Polymer Platform into new industries and applications.

Ulrich’s vision is that AMSilk’s bio technology and silk polymer products shall continue to our customers to change to better and more sustainable products in their industries. This generates everlasting change for customers and consumers, at the same time taking AMSilk to a new level.


Dr. Lin Römer

Lin Römer, Co-Founder and CTO of AMSilk, is an expert in chemistry and biochemistry. Lin cofounded AMSilk in 2008 and his dedication to making our game-changing biomaterials available to everyone is unwavering.

At AMSilk, Lin is at the forefront of technical development and key to transferring innovation into marketable products. His ambition is to further industrialize the production of AMSilk’s sustainable biomaterial products, extending our innovative biotech silk technology platform.


Leadership Team

Severin Bertsch
Head of Fiber Business

Tilmann Petersen
Head of Business Development Medtech & Corporate Planning

Dr. Tobias Kraxenberger
Head of Protein Production

Frédéric Bourcarde
Senior Production Manager Fiber BU

Advisory Board

Dr. Wolfgang Colberg
Industrial Partner

Michael Motschmann
Vice Chairman
General Partner and member of the Executive Board at MIG Fonds

Melissa Simon
Advisory Board Member
Direct- and Co- Investments at ATHOS KG

Anders Bendsen Spohr
Advisory Board Member
Senior Director at Novo Holdings A/S

Kartik Dharmadikari
Advisory Board Member
Partner at Novo Holdings A/S

Our shareholders

Our shareholders fully support our vision make the world’s best and most sustainable biomaterials accessible to everyone. Together we want AMSilk to become a global leader in biotech performance materials.

Our business model is based on collaboration, which is reflected by the sustainable relationships with our investors. We remain deeply grateful that our shareholders have remained with us since the very beginning of our journey.

In 2008 AMSilk was founded as spin-off from the Technical University of Munich. Thanks to the support of MIG Fonds, which invests in young, unlisted companies throughout the German-speaking region, and our majority shareholders Dr. Andreas and Dr. Thomas Strüngmann via AT Newtec GmbH   founders of Hexal – we were able to grow from a humble startup into a well-established, reputable industry partner in the field of biomaterial products.

Creating value through sustainable growth

The first step: Talking to us

Please contact us to learn more about AMSilk and our technology, materials and applications. We’d love to get in touch and explore how we can work together!